Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-06-01T13:59:04.169Z Has data issue: false hasContentIssue false
  • English
  • Français

The Use of Valerian in Neuropsychiatry

Published online by Cambridge University Press:  07 November 2014

Andrew D. Krystal  and
Ilana Ressler
Get access Rights & Permissions [Opens in a new window]

Abstract

Valerian is a medicinal agent deriving from the plant Valeriana officinalis L. We reviewed the available literature on the use of valerian preparations in the treatment of neuropsychiatric disorders. Preclinical studies suggest that valerian has sedative and muscle-relaxant effects. Few clinical trials with valerian have been carried out in conditions other than insomnia. The insomnia studies have methodologic shortcomings but suggest that some preparations lead to significant subjective improvement in sleep complaints with remarkably few side effects. Furthermore, some evidence indicates that valerian preparations may have a mechanism of action and clinical characteristics that differ from the benzodiazepine-related sedative/hypnotics, making them more suitable for long-term use. If this safety profile and the plant's sedative/hypnotic efficacy are confirmed in double-blind, placebo-controlled trials with carefully and consistently prepared valerian compounds, then those compounds would fill an important and presently unfilled niche in the treatment of insomnia.

Type
Feature Articles
Information
CNS Spectrums , Volume 6 , Issue 10: Empirical Evaluations of Selected Herbal Remedies , October 2001 , pp. 841 - 847
Copyright
Copyright © Cambridge University Press 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Barrett, B, Kiefer, D, Rabago, D. Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Altern Ther Health Med. 1999;5:40–49.Google ScholarPubMed
2. Solecki RS, Shanidar IV. A Neanderthal flower burial in northern Iraq. Science. 1975;190:880.CrossRefGoogle Scholar
3. Leathwood, PD, Chauffard, F, Heck, E, Munoz-Box, R. Aqueous extract of valerian root (Valeriana oficinalis L.) improves sleep quality in man. Pharmacol Biochem Behav. 1982;17:65–71.CrossRefGoogle Scholar
4. Plushner, S. Valerian: Valeriana officinalis. Am J Health Syst Pharm. 2000;57:328–335.CrossRefGoogle ScholarPubMed
5. O'Hara, M, Kiefer, D, Kemper, K. A review of 12 commonly used medicinal herbs. Arch Fam Med. 1998;7:523–536.CrossRefGoogle ScholarPubMed
6. Yager, J, Siegfreid, S, DiMatteo, T. Use of alternative remedies by psychiatric patients: illustrative vignettes and a discussion of the issues. Am J Psychiatry. 1999;156:1432–1438.CrossRefGoogle Scholar
7. Hobbs, C. Valerian. HerbalGram. 1989;21:19–34.Google Scholar
8. Williamson, JS, Wyandt, CM. Herbal therapies: the facts and the fiction. Drug Topics. 1997:78–85.Google Scholar
9. Wagner, J, Wagner, ML, Hening, WA. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacol. 1998;32:680–691.CrossRefGoogle ScholarPubMed
10. Houghton, PJ. The scientific basis for the reputed activity of Valerian. J. Pharm. Pharmacol. 1999;51:505–512.Google Scholar
11. Czabajska, W, Jaruzelski, M, Ubysz, D. New methods in the cultivation of Valeriana officinalis. Planta Medica. 1976;30:9–13.CrossRefGoogle ScholarPubMed
12. Steinegger, E, Hansel, R. Textbook of Pharmacognosy and Phytopharmacology. Berlin: Springer Publishers; Berlin, Germany. 1984: Section 10.5.5.Google Scholar
13. Sakamoto, T, Mitani, Y, Nakajima, K. Psychotropic effects of Japanese valerian root extract. Chem Pharm Bull (Tokyo). 1992;40:758–761.CrossRefGoogle ScholarPubMed
14. Hendriks, H, Bos, R, Allersma, P, Malingre, TM, Koster, AS. Pharmacologic screening of valerenal and some other components of essential oil of Valeriana officinalis. Planta Medica. 1981;42:62–68.CrossRefGoogle ScholarPubMed
15. Hendriks, H, Bos, R, Woerdenbag, HJ, Koster, ASJ. Central nervous depressant activity of valerenic acide in the mouse. Planta Medica. 1985;1:28–31.CrossRefGoogle Scholar
16. Andreatini, R, Leite, JR. Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal. Eur J Pharmacol. 1994;260:233–235.CrossRefGoogle ScholarPubMed
17. Hiller, KO, Zetler, G. Neuropharmacological studies on ethanol extracts of Valeriana officinalis L: behavioral and anticonvulsant properties. Phytother Res. 1996;10:145–151.3.0.CO;2-W>CrossRefGoogle Scholar
18. Wong, AH, Smith, M, Boon, HS. Herbal remedies in psychiatric practice. Arch Gen Psychiatry. 1998;55:1033–1044.CrossRefGoogle ScholarPubMed
19. Santos, MS, Ferreira, F, Cunha, AP, Carvalho, AP, Macedo, T. An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Medica. 1994;60:278–279.CrossRefGoogle ScholarPubMed
20. Santos, MS, Ferreira, F, Cunha, AP, Carvalho, AP, Macedo, T. The amount of GABA in an aqueous extract of valerian is sufficient to account for [3H]GABA release in synaptosomes. Planta Medica. 1994;60:475–476.CrossRefGoogle Scholar
21. Santos, MS, Ferreira, F, Cunha, AP, Carvalho, AP, Macedo, T. Synaptosomal GABA release as influenced by valerian root extract—involvement of the GABA carrier. Arch Int Pharmacodynammics. 1994;327:220–231.Google ScholarPubMed
22. Bodesheim, U, Holzl, J. Isolierung, strukturaufknlorung und radiorezeptorassays von alkaloiden und lignanen aus Valeriana officialis L. Pharmazie. 1997;52:387–391.Google ScholarPubMed
23. NCSDR Working Group. Insomnia: assessment and management in primary care. Sleep. 1999;22(suppl 2):S343–S412.Google Scholar
24. Donath, F, Quispe, S, Diefenbach, K, et al. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry. 2000;33:47–53.CrossRefGoogle ScholarPubMed
25. Dominguez, RA, Bravo-Valverde, RL, Kaplowitz, BR, Cott, JM. Valerian as a hypnotic for Hispanic patients [cultural diversity and ethnic minority psychology]. 2000;6:84–92.CrossRefGoogle ScholarPubMed
26. Seifert, T. Therapeutic effects of valerian in nervous disorders. Therapeutikon. 1988;2:94–98.Google Scholar
27. Schmidt-Voigt, J. Treatment of nervous sleep disturbances and inner restlessness with a purely herbal sedative. Therapiewoche. 1986;36:663–667.Google Scholar
28. Lindahl, O, Lindwall, L. Double-blind study of a valerian preparation. Pharmacol Biochem Behav. 1989;32:1065–1066.CrossRefGoogle ScholarPubMed
29. Kamm-Kohl, AV, Jansen, W, Brockmann, P. Modern valerian therapy of nervous disorders in elderly patients. Medwelt. 1984;35:1450–1454.Google Scholar
30. Leathwood, PD, Chauffard, F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Medica. 1985;51:144–148.CrossRefGoogle Scholar
31. Edinger, JD, Fins, AI, Glenn, DM, et al. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints? J Consul Clin Psychol. 2000;68:586–593.CrossRefGoogle ScholarPubMed
32. Krystal, AD, Edinger, SD, Wohlgemuth, WK, Marsh, GR. A pilot study of the sleep EEG power spectral effects of behavioral therapy in primary insomniacs. Sleep. 2001;24:A59Google Scholar
33. Balderer, G, Borbély, AA. Effect of valerian on human sleep. Psychopharmacology. 1985;87:406–409.CrossRefGoogle ScholarPubMed
34. Schulz, H, Stolz, C, Muller, J. The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry. 1994;27:147–151.CrossRefGoogle ScholarPubMed
35. Oshima, Y, Matsuoka, S, Ohizumi, Y. Antidepressant principles of Valeriana fauriei roots. Chem Pharm Bull (Tokyo). 1995;43:169–170.CrossRefGoogle ScholarPubMed
36. Kuhlmann, J, Berger, W, Podzuweit, H, Schmidt, U. The influence of valerian treatment on “reaction time, alertness and concentration“ in volunteers. Pharmacopsychiatry. 1999;32:235–241.CrossRefGoogle Scholar
37. Macgregor, FB, Abernathy, VE, Dahabra, S, Cobden, I, Hayes, PC. Hepatotoxicity of herbal remedies. BMJ. 1989;299:1156–1157.CrossRefGoogle ScholarPubMed
38. Tortarolo, M, Braun, R, Hubner, GE, Maurer, HR. In vitro effects of epoxide bearing valepotriates on mouse early hematopoietic progenitor cells and human T-lymphocytes. Arch Toxicol. 1982;51:37–42.CrossRefGoogle Scholar